{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T11:57:32Z","timestamp":1759147052841,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2022YFC2504100"],"award-info":[{"award-number":["2022YFC2504100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171110"],"award-info":[{"award-number":["82171110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"publisher","award":["Z211100002921057"],"award-info":[{"award-number":["Z211100002921057"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7222024"],"award-info":[{"award-number":["7222024"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Several epidemiological studies have shown that allergic rhinitis (AR) patients are more susceptible to coronavirus disease 2019 (COVID-19).<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We aim to investigate the risk factors for COVID-19 in AR patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective nationwide cohort study was conducted based on a questionnaire survey in China. The baseline characteristics, region of residence, smoking and drinking status, comorbidities, vaccination status and previous infection information were obtained. Allergen test results, the SARS-CoV-2 nucleic acid test, and antigen detection results were collected. Information on AR and comorbid medication use pre-SARS-CoV-2 infection was also collected. Binary logistic regression and analysis of covariance (different adjusted models) were conducted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In all, 830 AR patients were included; 627 patients (75.54%) were infected with SARS-CoV-2. AR comorbid with allergic conjunctivitis (AC) was a protective factor [OR: 0.525 (95% CI\u2009=\u20090.296\u20130.929), <jats:italic>P<\/jats:italic>\u2009=\u20090.027] against SARS-CoV-2 infection, while AR comorbid with food allergy was a risk factor [OR: 6.404 (95% CI\u2009=\u20091.349\u201330.402), <jats:italic>P<\/jats:italic>\u2009=\u20090.0195]. Although fewer patients received four doses of the vaccine, the results showed a significant protective effect against SARS-CoV-2 infection in AR patients [OR: 0.093 (95% CI\u2009=\u20090.025\u20130.348), <jats:italic>P<\/jats:italic>\u2009=\u20090.0004]. Underweight was a protective factor against COVID-19 [OR: 0.287 (95% CI\u2009=\u20090.147\u20130.562), <jats:italic>P<\/jats:italic>\u2009=\u20090.0003] after full multivariable adjustment. Overweight was associated with a 2.071-fold higher risk for COVID-19 compared with normal weight [(95% CI\u2009=\u20091.045\u20134.105), <jats:italic>P<\/jats:italic>\u2009=\u20090.0370]. Additionally, house dust mite (HDM)-specific allergies were also protective against COVID-19 [OR: 0.537 (95% CI\u2009=\u20090.290\u20130.996), <jats:italic>P<\/jats:italic>\u2009=\u20090.0484].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study revealed underlying protective and risk factors, which might be used to improve the management of AR and COVID-19.<\/jats:p><\/jats:sec>","DOI":"10.3389\/falgy.2024.1479493","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T06:34:18Z","timestamp":1733812458000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk and protective factors for coronavirus disease 2019 (COVID-19) in allergic rhinitis patients: a national survey in\u00a0China"],"prefix":"10.3389","volume":"5","author":[{"given":"Xiaozhe","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Sima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangdong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1038\/s41467-020-18272-4","article-title":"Substantial underestimation of Sars-Cov-2 infection in the United States","volume":"11","author":"Wu","year":"2020","journal-title":"Nat Commun"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1111\/all.15044","article-title":"Advances and highlights in allergic rhinitis","volume":"76","author":"Zhang","year":"2021","journal-title":"Allergy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jaci.2014.04.024","article-title":"Risks for infection in Patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?","volume":"134","author":"Juhn","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jaci.2017.03.050","article-title":"Allergic rhinitis and its impact on asthma (Aria) guidelines-2016 revision","volume":"140","author":"Bro\u017cek","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/all.12874","article-title":"An increased prevalence of self-reported allergic rhinitis in Major Chinese cities from 2005 to 2011","volume":"71","author":"Wang","year":"2016","journal-title":"Allergy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"14274","DOI":"10.3390\/ijerph192114274","article-title":"Incidence of asthma, atopic dermatitis, and allergic rhinitis in Korean adults before and during the COVID-19 pandemic using data from the Korea National Health and nutrition examination survey","volume":"19","author":"Choi","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaci.2020.04.030","article-title":"Perspective: COVID-19, Implications of nasal diseases and consequences for their management","volume":"146","author":"Jian","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaci.2020.08.008","article-title":"Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study","volume":"146","author":"Yang","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1111\/all.15823","article-title":"The association between allergic rhinitis and the risk of coronavirus disease 2019 (COVID-19): a national survey in China","volume":"78","author":"Yang","year":"2023","journal-title":"Allergy"},{"key":"B11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/all.14569","article-title":"Angiotensin-Converting enzyme ii expression and its implication in the association between COVID-19 and allergic rhinitis","volume":"76","author":"Wang","year":"2021","journal-title":"Allergy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jaip.2021.10.049","article-title":"Impact of allergic rhinitis and asthma on COVID-19 infection, hospitalization, and mortality","volume":"10","author":"Ren","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.15586\/aei.v49i5.105","article-title":"Investigating the association between allergic diseases and COVID-19 in 400 Iranian patients","volume":"49","author":"Darabi","year":"2021","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3760\/cma.j.cn112338-20221231-01092","article-title":"Epidemiological survey of 2019-nCoV infection in staff and students in some public health schools in China","volume":"44","author":"Wei","year":"2023","journal-title":"Chin J Epidemiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"154373","DOI":"10.1016\/j.metabol.2020.154373","article-title":"Association of body mass Index (bmi) with critical COVID-19 and in-hospital mortality: a dose-response meta-analysis","volume":"117","author":"Du","year":"2021","journal-title":"Metab Clin Exp"},{"key":"B16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1161\/CIRCULATIONAHA.120.051936","article-title":"Association of body mass Index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 cardiovascular disease registry","volume":"143","author":"Hendren","year":"2021","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.mayocp.2020.05.006","article-title":"Obesity and outcomes in COVID-19: when an epidemic and pandemic collide","volume":"95","author":"Sanchis-Gomar","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"B18","doi-asserted-by":"publisher","first-page":"649422","DOI":"10.3389\/fnut.2021.649422","article-title":"Both underweight and obesity are associated with an increased risk of coronavirus disease 2019 (COVID-19) severity","volume":"8","author":"Ye","year":"2021","journal-title":"Front Nutr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"101205","DOI":"10.1016\/j.arr.2020.101205","article-title":"Aging in COVID-19: vulnerability, immunity and intervention","volume":"65","author":"Chen","year":"2021","journal-title":"Ageing Res Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1016\/j.jaip.2020.08.009","article-title":"Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis","volume":"8","author":"Ferreli","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/all.15048","article-title":"Antiviral response in Vernal Keratoconjunctivitis may be protective against COVID-19","volume":"77","author":"Leonardi","year":"2022","journal-title":"Allergy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jaci.2022.05.014","article-title":"Risk factors for Sars-Cov-2 infection and transmission in households with children with asthma and allergy: a prospective surveillance study","volume":"150","author":"Seibold","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1016\/j.jaip.2020.07.019","article-title":"Impact of the COVID-19 pandemic in children with allergic asthma","volume":"8","author":"Ruano","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12967-022-03382-y","article-title":"Early and strong antibody responses to Sars-Cov-2 predict disease severity in COVID-19 patients","volume":"20","author":"Pl\u016bme","year":"2022","journal-title":"J Transl Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1056\/NEJMoa2201688","article-title":"Fourth dose of Bnt162b2 Mrna COVID-19 vaccine in a nationwide setting","volume":"386","author":"Magen","year":"2022","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1056\/NEJMc2202542","article-title":"Efficacy of a fourth dose of COVID-19 Mrna vaccine against Omicron","volume":"386","author":"Regev-Yochay","year":"2022","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jaci.2006.04.060","article-title":"Distribution and determinants of house dust Mite allergens in Europe: The European Community Respiratory Health Survey II","volume":"118","author":"Zock","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.clim.2017.09.008","article-title":"Increased innate type 2 immune response in house dust mite-allergic patients with allergic rhinitis","volume":"183","author":"Zhong","year":"2017","journal-title":"Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.chom.2021.05.004","article-title":"Innate immune and inflammatory responses to Sars-Cov-2: implications for COVID-19","volume":"29","author":"Lowery","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jaci.2020.04.009","article-title":"Association of respiratory allergy, asthma, and expression of the Sars-Cov-2 receptor Ace2","volume":"146","author":"Jackson","year":"2020","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2024.1479493\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T06:34:23Z","timestamp":1733812463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2024.1479493\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":30,"alternative-id":["10.3389\/falgy.2024.1479493"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2024.1479493","relation":{},"ISSN":["2673-6101"],"issn-type":[{"type":"electronic","value":"2673-6101"}],"subject":[],"published":{"date-parts":[[2024,12,10]]},"article-number":"1479493"}}